The MarketWatch News Department was not involved in the creation of this content.-- FB301 was safe and well tolerated in healthy female subjects, with all primary and secondary en ...
Essential3 is the first positive Phase 3 program in essential tremor; ulixacaltamide has received FDA Breakthrough Therapy Designation, with data selected for plenary presentation at AAN 2026 Praxis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results